Pfizer Plaintiffs Defend Robbins Geller Fees In $400M Deal
By Joe Van Acker ( June 8, 2015, 4:51 PM EDT) -- Plaintiffs pushing for final approval of a $400 million settlement with Pfizer Inc. in an off-label marketing class action urged a New York federal judge on Friday to overrule objections to a $94 million fee request by lead counsel from Robbins Geller Rudman & Dowd LLP....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.